Trials / Unknown
UnknownNCT04263623
Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidrosis
A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Moderate to Severe Palmar Hyperhidrosis
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Atacama Therapeutics · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, randomized, double-blind, placebo-controlled, parallel group comparison study of AT-5214 in subjects with moderate to severe primary palmar hyperhidrosis (sweaty palms). This study will compare two different oral (tablet) doses of AT-5214 (study drug) versus a matched placebo. Approximately 120 subjects will be enrolled at approximately 10 study sites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmecamylamine HCl | Investigational drug |
| OTHER | Placebo | Oral tablet containing no active drug. |
Timeline
- Start date
- 2020-01-31
- Primary completion
- 2020-12-03
- Completion
- 2021-09-01
- First posted
- 2020-02-11
- Last updated
- 2021-07-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04263623. Inclusion in this directory is not an endorsement.